Optimal Management of CAR T-Cell Toxicities: An Interactive Algorithm Tool and Toxicity Management Resource for Clinicians

Use this Interactive Decision Support Tool to obtain strategies to assess and manage CAR T-cell therapy–associated toxicities from 5 renowned multidisciplinary experts.

Matthew J. Frigault, MD
Program Director Daniel J. DeAngelo, MD, PhD Ilene A. Galinsky, NP Jae H. Park, MD Shilpa Paul, PharmD, BCOP Released: May 8, 2019

Review expert insights and recommendations on the evolving multidisciplinary management of cytokine-release syndrome and neurotoxicity associated with CAR T-cell therapies.

Matthew J. Frigault, MD
Program Director Physicians: maximum of 1.75 AMA PRA Category 1 Credits™ Registered Nurses: 1.7 Nursing contact hours Pharmacists: 1.75 contact hours (0.175 CEUs) Released: May 17, 2019 Expired: May 16, 2020

In this downloadable slideset with slidenotes featuring expert commentary, review the biologic principles underlying toxicities associated with CAR T-cell therapy and how to leverage multidisciplinary strategies to manage these unique adverse events.

Matthew J. Frigault, MD
Program Director Released: May 17, 2019

A resource guide describing how CAR T-cells are manufactured, approved CAR T-cell therapies, tips on screening/diagnosis/monitoring, and guidance on managing CAR T-cell-associated toxicities.

Matthew J. Frigault, MD
Program Director Released: April 10, 2019